Sganga, S.; Riondino, S.; Iannantuono, G.M.; Rosenfeld, R.; Roselli, M.; Torino, F.
Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. J. Pers. Med. 2023, 13, 1339.
https://doi.org/10.3390/jpm13091339
AMA Style
Sganga S, Riondino S, Iannantuono GM, Rosenfeld R, Roselli M, Torino F.
Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. Journal of Personalized Medicine. 2023; 13(9):1339.
https://doi.org/10.3390/jpm13091339
Chicago/Turabian Style
Sganga, Stefano, Silvia Riondino, Giovanni Maria Iannantuono, Roberto Rosenfeld, Mario Roselli, and Francesco Torino.
2023. "Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives" Journal of Personalized Medicine 13, no. 9: 1339.
https://doi.org/10.3390/jpm13091339
APA Style
Sganga, S., Riondino, S., Iannantuono, G. M., Rosenfeld, R., Roselli, M., & Torino, F.
(2023). Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. Journal of Personalized Medicine, 13(9), 1339.
https://doi.org/10.3390/jpm13091339